I don't know if we'll ever be super liquid here, but I do believe buyers will come in at some point, and depending on what the financials look like hopefully will see $3+ again.
I look at OTC:COSM as perhaps a similarity, as Panos Tolis also assisted in taking that company public on the OTC as well. A lot of foreign companies that go public in the US don't have anyone with much knowledge of the US public markets, however, Panos seems to have a lot from what I can tell.